Jeff Yass’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXO
Jeff Yass's ALXO Position: Q3 2026 in Review
Jeff Yass reduced its ALX Oncology (ALXO) stake by 56% in Q3 2026, selling an estimated $133K and leaving 54,307 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12715.
Jeff Yass first reported a position in ALXO in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.66M in Q1 2026. 112 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.
- Jeff Yass held 54,307 shares of ALX Oncology worth $75.5K as of Q3 2026.
- Jeff Yass sold 68,850 ALX Oncology shares in Q3 2026, an estimated $133K.
- ALX Oncology made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12715 holding.
- Jeff Yass first reported a position in ALX Oncology in Q4 2020 and has held it in 22 quarters since.
- Jeff Yass's ALX Oncology position peaked at $2.66M in Q1 2026.
- 112 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.